EIHA says its CBD research will satisfy EU food safety agency’s requirements

Source: HempToday.net | Author: Hemp Today | June 22, 2022

EIHA projects GmbH, a consortium of the European Industrial Hemp Association (EIHA), said research it is currently conducting on the safety of CBD will meet the expectations of the European Food Safety Authority (EFSA).

Concern about safety on the part of EFSA “is definitely not a surprise and 100% in line with our approach,” EIHA said in a statement.

EFSA earlier this month said it had identified gaps in research regarding the effects of CBD on humans, declaring “the safety of CBD as a novel (new) food cannot currently be established.”

The EIHA consortium is spending €2.5 to €3 million on extensive toxicology and clinical research regarding CBD and THC which will be the basis for its novel food applications, which cover isolates and full-spectrum formulations.

Pooling resources

“We decided in 2021 to pool the resources of more than 100 companies and work . . . on a serious and solid submission, anticipating the scientific gaps indicated by EFSA,” EIHA said.

While EFSA has not concluded that CBD consumption is dangerous, the agency said in a statement issued earlier this month that research currently available on the compound’s effects on the liver, gastrointestinal tract, endocrine system, nervous system, and on psychological well-being is insufficient.

The EFSA statement was a response to the European Commission, which sought input from the agency’s experts regarding the safety of CBD. The Commission has said CBD can be classified as a new or “novel” food if it meets relevant provisions in EU food legislation.

Cutting costs

EIHA formed the consortium as a way to reduce the cost of the EU’s novel food approval procedure to its members. The Association estimates the cost of getting a single product approved under novel food rules as ranging from €350,000 to €500,000 per product.

Participation in the EIHA consortium, structured in two categories, significantly reduces those costs. In the first category, producers of hemp biomass and raw materials, makers of processed extracts, premixes, oils, and isolates as well as service providers pay fees according to an eight-tier payment structure which ranges from €20,000 for those with CBD-related income of €1 million or less, up to €330,000 for those with income of €50 million or more. Consortium participants are also required to join the EIHA on a parallel rate scale that ranges from €2,500 to €25,000.

Under a companion 12-tier sublicensing program for white-label operators, fees range from €1,800 for companies with income of €10,000 or less up to €405,000 for those with income of €50 million or more.

Novel food in the EU

Europe’s novel food rules were created to control new, genetically or synthetically produced food products before market entry. Under the guidelines, novel foods are defined as those that were not consumed to a significant degree in the EU before May 15, 1997. If a food is considered novel it must undergo a pre-market safety assessment under EFSA before it can be legally marketed in the EU.

ChemSafe, an Italian consultancy that has experience in the chemical, pharmaceutical, biocides, agrochemical, cosmetics, medical devices and food sectors, is heading the science-based analysis of CBD and THC on behalf of EIHA.

EFSA has scheduled an information session June 28, during which agency representatives will answer questions and provide guidance to current novel food applicants regarding the research gaps identified. A total of 19 CBD applications are now before the agency.

Czech change on THC limit sets an example for other EU states

Source: HempToday.net | Author: Hemp Today | Sept 27, 2021

Amendments to Czech law that would raise the national THC limit for industrial hemp to 1.0% could spark other EU countries to revisit their current limits. But the change is not likely to affect farmers, who can’t qualify for subsidies if their hemp crops are over the EU limit of 0.2%, and food and cosmetics rules still must be changed to establish a legal pathway to market for those products.

Czech President Miloš Zeman is expected to sign the bill after the Parliament’s Chamber of Deputies sent it to his desk earlier this month.

Changing the amount of THC allowable in hemp plants to 1.0% would put the Czech limit well beyond that of the EU, even after the European Parliament voted last October to increase the authorized THC level for industrial hemp “on the field” from 0.2% to 0.3%.

Farm subsidies critical

In addition to direct cash offsets, many European farmers growing hemp have depended on direct subsidies or EU Rural Development Programme funds as security for agricultural loans and deferred payments. To be eligible for those funds, farmers’ crops may not go beyond the EU’s 0.2% THC limit despite local laws which may be different.

But the Czech law pushing the THC level beyond the EU limit could nonetheless serve as a beacon to other member states, stakeholders say.

“It’s definitely an interesting signal to other EU countries, and maybe it can eventually help to bring the European THC level to 1.0% in the long run,” said Boris Baňas, Chief Sales Officer at Czech-based CBDepot, who estimated that process could take “more than a year or two.”

While the EU-wide change to 0.3% THC is not expected to be in effect until 2023, member states are now in the process of adjusting their national laws to align with the updated limit after the change was included in the most recent round of Common Agricultural Policy (CAP) reforms.

Trend to 1.0% THC

Many nations around the world are establishing 1.0% THC as their national limits, breaking with the generally accepted global guidance of 0.3% that has been observed since hemp re-emerged in the 1990s.

“Many countries are at 1% already, including Switzerland and Australia,” said veteran American cannabis consultant Richard Rose, who has suggested that certification of hemp varieties should imply legal THC levels. “Not testing THC for approved varieties is what I’ve been advocating for years, since government certification should count for SOMEthing,” Rose said.

The higher limit is important especially for CBD producers; higher THC means higher levels of CBD, as the two compounds rise in proportion. For farmers, it means much less risk of their crops going “hot,” or over the allowable THC level.

“EIHA welcomes this modern approach to THC limits, which is in line with the global development of commercial hemp cultivation,” European Industrial Hemp Association President Daniel Kruse said of the new Czech law.

Decriminalizing extracts

Aside from resetting the THC limit for hemp “on the field,” the new law would mean possession of hemp extracts and tinctures with less than 1% THC won’t be considered a criminal act. “But it doesn’t mean you can infuse any food or cosmetics as such,” Baňas said. Those rules must still be changed to create a legal market.

In a report to Czech Senators outlining the new law, CzecHemp, a stakeholder cluster, said the package of amendments “opens the possibility to manufacture and market products up to a maximum of 1.0% of tetrahydrocannabinol,” but notes that provisions in the new law are “without prejudice to other regulations,” and that products “must be safe and non-misuse.”

While the new law won’t lead to immediate marketability of food and cosmetics, it would decriminalize hemp-based health aids or “cosmetics” often home-made by Czech seniors, according to CzecHemp.

Little effect on processing

While the THC limit change could lead to more latitude and less bureaucracy for extractors, Baňas is skeptical about that. “THC often goes over 1% in hemp processing,” he said. “That means those companies will still need to have authorization for handling that material.”

Under the updated medical cannabis provisions in the new law, multiple licensed private groups could be authorized to manufacture medical cannabis products. Proponents say the changes would expand the availability and diversity of products through competition certain to drive down prices to patients.

In other interpretations from CzecHemp, the new law also:

  • Introduces the term “technical hemp,” (industrial hemp) defined as a plant which comes from seeds listed in the European Catalog or from which hemp with a content of up to 1% THC can be produced.
  • Removes a requirement that processors of “technical cannabis” have authorization to handle addictive substances.
  • Establishes the term “hemp extract for medical use” defined as “intended for the preparation of an individually prepared medicinal product.” CzecHemp said the State Institute for Drug Control must still amend existing legislation to set conditions for “prescribing, preparation, distribution, dispensing and use of individually prepared medicinal products containing cannabis for therapeutic use.”